Pasritamig Antibody
Pasritamig is a bispecific T-cell engager antibody designed to target kallikrein 2 (KLK2) and CD3E. Its IgG1-scFv format facilitates the redirection of T-cells against KLK2-expressing cells, supporting research in prostate cancer immunotherapy for in vitro cytotoxicity assays and in vivo efficacy studies.
Product Specifications
Target
Others
Clonality
Recombinant
Conjugation
Unconjugated
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog